Physician profile
Mujda Zhublawar
NPI 1154454395
$1,063.78
in general payments reported to CMS, 2019-2025
7 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Occupational Vision provider received nationally (typical 2025 total: $169).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.84 · 2020: $171 · 2021: $176 · 2022: $85.57 · 2023: $188 · 2024: $210 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $584.91 | 2019-2024 | Acuvue |
| Coopervision INC. | $199.90 | 2019-2023 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $191.95 | 2022-2025 | |
| Alcon Vision LLC | $30.03 | 2019-2021 | |
| Allergan, INC. | $22.84 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $21.81 | 2024 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mujda Zhublawar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.